Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $2,367.0M | $1,098.0M | $1,290.0M | $2,310.0M | $2,766.0M | $3,335.0M | $4,067.0M | $4,473.0M | $6,393.0M | $3,008.0M | $2,622.0M | $1,012.0M | $1,635.0M | $4,220.0M | $4,989.0M | $7,231.0M | $13.3B | $15.2B | $11.9B | $12.7B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Bristol-Myers Squibb Company's last 12-month Free Cash Flow is $13.8B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Bristol-Myers Squibb Company's Free Cash Flow growth was 18.1%. The average annual Free Cash Flow growth rates for Bristol-Myers Squibb Company have been 1.4% over the past three years, 12.7% over the past five years.
Over the last year, Bristol-Myers Squibb Company's Free Cash Flow growth was 18.1%, which is higher than industry growth of (0.2%). It indicates that Bristol-Myers Squibb Company's Free Cash Flow growth is Good.